Arkolith/Insider Trading/APTO/Form 4

Payne Fletcher

InsiderAptose Biosciences Inc. (APTO) · full profile →Form 4 · filed Jul 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Disposed to issuer(D)222$1.72$3820
Jun 30, 2026Disposed to issuer(D)22$1.72$380

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Disposed to issuer(D)55K—$00
Jun 30, 2026Disposed to issuer(D)200K—$00
Jun 30, 2026Disposed to issuer(D)1.0M—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-26-000895) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML